The original NHS, NICE, charity and research pages on this topic, with our summary of each.
NHS
Web page
Oct 2026
For patients
The NHS medicine guide to prednisolone, a steroid that calms inflammation and is used in conditions including Crohn's disease. It covers how to take it, side effects, and why you may be given a blue steroid card and a red steroid emergency card depending on how long you take it.
Topics
Steroids
Medicines
Jargon explained
corticosteroid
steroid emergency card
adrenal insufficiency
NHS
Web page
Aug 2026
For patients
The NHS medicine guide to adalimumab, listing brands such as Amgevita, Humira, Imraldi and Yuflyma. It explains that it treats autoimmune conditions including Crohn's disease, is usually started by a specialist after other medicines have not worked, and needs regular blood tests.
Topics
Biologics and newer medicines
Medicines
Jargon explained
biologic
autoimmune condition
biosimilar
Crohn's & Colitis UK
Web page
Jul 2026
For patients
Explains how new IBD medicines move from lab testing through clinical trials to licensing, and describes medicines currently in late-stage testing.
Topics
Research
Medicines
Jargon explained
clinical trial
licensing
phase 3
NHS
Web page
May 2026
For patients
The NHS says only very small amounts of most medicines pass into breast milk and very few are unsafe while breastfeeding. It advises always telling your GP, midwife, health visitor or pharmacist that you are breastfeeding when a medicine is discussed.
Topics
Pregnancy and fertility
Medicines
Jargon explained
breastfeeding
NHS
Web page
Jun 2025
For patients
A general NHS explainer on steroid medicines (corticosteroids), which mimic hormones the body makes and reduce inflammation. It lists Crohn's disease among the conditions treated, explains the different forms steroids come in, and covers common side effects.
Topics
Steroids
Medicines
Jargon explained
corticosteroids
anabolic steroids
NHS
Web page
Mar 2023
For patients
The NHS introduction to methotrexate, an immunosuppressant used for Crohn's disease, arthritis and psoriasis. It explains the forms it comes in, that it is taken once a week for these conditions, and why you carry a patient card and need to take care with infections and vaccines.
Topics
Immunosuppressants
Medicines
Jargon explained
immunosuppressant
inflammation
NHS
Web page
Mar 2023
For patients
NHS guidance on taking methotrexate safely: the same day each week, what to do if you miss a dose or take too much, why folic acid is taken on a different day, and how often blood tests are needed at first and once treatment is stable.
Topics
Immunosuppressants
Medicines
Monitoring
Jargon explained
folic acid
blood test monitoring
NHS
Web page
Mar 2023
For patients
The NHS list of common and serious methotrexate side effects, with tips for coping with sickness, diarrhoea and tiredness. It explains which warning signs of liver, lung, kidney, blood or infection problems need urgent advice, and notes sun sensitivity and possible long-term liver or lung effects.
Topics
Immunosuppressants
Medicines
Jargon explained
anaphylaxis
sun sensitivity
NHS
Web page
Mar 2023
For patients
A short NHS page on who should check with their doctor before taking methotrexate, such as people with liver or kidney disease, infections, ulcers or a planned live vaccine. It notes you may have a chest X-ray and breathing test first.
Topics
Immunosuppressants
Medicines
Jargon explained
live vaccine
duodenal ulcer
GOV.UK
Web page
For patients
Government rules on carrying medicines into and out of the UK. It advises asking your doctor or pharmacist whether a medicine is a controlled drug, explains when you need a prescription or a letter from your doctor as proof the medicine is yours, and says to check the rules of the country you are visiting.
Topics
Travel
Medicines
Jargon explained
controlled drugs
NHS England
Web page
Patients and professionals
NHS England's page on biosimilars: biological medicines shown to have no meaningful differences in quality, safety or effectiveness from the original brand. It explains why the NHS encourages their use, that switching between the original and a biosimilar is now accepted practice, and how savings are reinvested.
Topics
Biologics and newer medicines
Medicines
Jargon explained
biosimilar
originator medicine
switching
NHS
Web page
Oct 2026
For patients
NHS medicine guide to azathioprine. It lists skin becoming more sensitive to sunlight as a common side effect, says it may not suit people recently given a live vaccine such as chickenpox or yellow fever, and says it can be used in pregnancy if a specialist recommends it, pointing to the Bumps website for more.
Topics
Immunosuppressants
Cancer risk and screening
Pregnancy and fertility
Medicines
Jargon explained
azathioprine
thiopurine
live vaccine
immunosuppressant
DMARD
bone marrow
NHS
Web page
Dec 2023
For patients
The NHS overview of Crohn's: a lifelong condition where part of the gut becomes inflamed, with no cure yet but treatments that can control it. It lists the usual symptoms, explains that symptoms come and go in flare-ups and remissions, and says there is no single test, so diagnosis usually involves blood and poo tests from the GP followed by camera tests, biopsies and scans in hospital. It also covers possible causes (genes, smoking, a recent stomach bug, recent appendix removal) and when to get urgent help.
Topics
About Crohn's disease
Symptoms
Diagnosis and tests
Flare-ups
Diet and nutrition
Pregnancy and fertility
Living well
Complications
Medicines
Surgery
Jargon explained
inflammation
flare-up
remission
colonoscopy
endoscopy
biopsy
fistula
stricture
gastroenterologist
inflammatory bowel disease
anal fissure
perforation
nsaids
biologics
stoma
Crohn's & Colitis UK
Guide
Dec 2023
For patients
Covers treatments beyond the main drug groups: medicines for symptoms such as diarrhoea and pain, antibiotics for complications, nutritional treatments and supplements, and newer approaches only available through clinical trials.
Topics
Medicines
Diet and nutrition
Research
Jargon explained
antibiotics
nutritional therapy
faecal microbiota transplant
Crohn's & Colitis UK
Guide
For patients
A guide to upadacitinib (Rinvoq), a tablet that belongs to the JAK inhibitor group of targeted medicines. It explains how blocking JAK proteins calms the immune response, what trials showed, and the side effects and safety checks involved.
Topics
Medicines
Biologics and newer medicines
Jargon explained
JAK inhibitor
Janus kinase
targeted medicine
small molecule
Crohn's & Colitis UK
Guide
For patients
Explains the basics behind IBD medicines: active and inactive ingredients, brand and generic names, and what biosimilars are. It uses infliximab as an example, explaining that biosimilars meet strict standards and you may sometimes be moved to a different one.
Topics
Medicines
Biologics and newer medicines
Jargon explained
biosimilar
originator
generic
Crohn's & Colitis UK
Guide
Aug 2026
For patients
The charity's guide to steroids for Crohn's and Colitis, covering prednisolone, budesonide (brands such as Budenofalk and Entocort) and other forms. It explains side effects, why steroids are only for short-term use, why you must never stop suddenly, how the dose is gradually reduced, the risk of adrenal insufficiency, and carrying a steroid card.
Topics
Steroids
Medicines
Jargon explained
corticosteroids
budesonide
tapering
adrenal insufficiency
steroid card
Crohn's & Colitis UK
Guide
Aug 2025
For patients
Guides people through planning a pregnancy and giving birth with Crohn's or Colitis. It explains why being in remission matters, which tests and medicines are considered safe in pregnancy (and which, like methotrexate, must be stopped well beforehand), and that a higher dose of folic acid may be advised for some people, such as those with small bowel Crohn's or on sulfasalazine. It also covers birth choices, including when a caesarean may be recommended.
Topics
Pregnancy and fertility
Medicines
Jargon explained
remission
folic acid
caesarean section
methotrexate
Crohn's & Colitis UK
Guide
Aug 2025
For patients
Covers looking after yourself after birth and deciding whether breastfeeding is right for you while on Crohn's medicines. It says most biologics are thought to be compatible with breastfeeding, but advice varies by medicine. If you took immune-lowering medicines during pregnancy, your baby's live vaccines may need to be delayed, so tell the baby's healthcare team. Non-live vaccines are thought to be safe.
Topics
Pregnancy and fertility
Medicines
Vaccinations and infections
Jargon explained
breastfeeding
biologics
live vaccine
postnatal
Crohn's & Colitis UK
Guide
Jun 2024
For patients
A detailed guide to the thiopurine medicines azathioprine (Imuran, Jayempi) and mercaptopurine (6-MP). It explains how they work, how well they worked in trials, the TPMT enzyme test before starting, the regular blood tests needed throughout treatment, and possible side effects.
Topics
Immunosuppressants
Medicines
Monitoring
Jargon explained
thiopurine
TPMT
6-MP
bone marrow
immunosuppressant
Crohn's & Colitis UK
Guide
Jul 2023
For patients
An overview of biologics and other targeted medicines for Crohn's and Colitis, with a table of each medicine, its brand names and how it works. It explains that biologics are lab-made antibodies given by drip or injection, and covers biosimilars, anti-TNFs, interleukin inhibitors and JAK inhibitors.
Topics
Biologics and newer medicines
Medicines
Jargon explained
biologic
biosimilar
anti-TNF
IL-23 inhibitor
JAK inhibitor
advanced therapy
Crohn's & Colitis UK
Guide
Mar 2023
For patients
The charity's guide to methotrexate for Crohn's and Colitis, available as tablets or injections (brands include Metoject and Nordimet). It explains how it works, what trials showed, that it can be given alongside a biologic to reduce the antibodies the body makes against it, and the monitoring needed.
Topics
Immunosuppressants
Medicines
Jargon explained
immunosuppressant
antibodies
subcutaneous injection
Crohn's & Colitis UK
Guide
Dec 2023
For patients
Covers why diarrhoea happens in Crohn's and Colitis, including inflammation and bile acid malabsorption after the end of the small bowel is inflamed or removed, which can also cause greasy, floating poo. Warns not to take anti-diarrhoea medicines during a flare, with a temperature or with blood in your poo because of the risk of toxic megacolon, and explains bile acid binders.
Topics
Toilet habits
Symptoms
Medicines
Jargon explained
bile acid malabsorption
steatorrhoea
toxic megacolon
bile acid binders
stricture
Cochrane
Systematic review
Feb 2019
Patients and professionals
Antibiotics may give a small benefit for active Crohn's, but probably not enough to make a real difference for most people. They did not cause more side effects than placebo. Whether they help keep Crohn's in remission is unclear. Note this is about treating the Crohn's itself, not infections or abscesses.
Topics
Medicines
Research
Jargon explained
antibiotic
clinically meaningful
antibiotics
induction
maintenance
Cochrane
Systematic review
Jul 2016
Patients and professionals
Mesalazine-type drugs (aminosalicylates) are widely used for ulcerative colitis, but this review found little evidence that they work for active Crohn's. Low and high doses of mesalazine were not clearly better than placebo. Some trials comparing high-dose mesalazine with budesonide gave mixed results.
Topics
Medicines
Jargon explained
aminosalicylate
5-ASA
mesalazine
Cochrane
Systematic review
Apr 2023
Patients and professionals
Faecal microbiota transplant (FMT) means putting poo from a healthy donor into the bowel to change the gut bacteria. For Crohn's, the evidence is very uncertain and no conclusions could be drawn about whether it works. More trials are needed.
Topics
Research
Medicines
Jargon explained
faecal microbiota transplant
microbiome
Cochrane
Systematic review
Jul 2020
Patients and professionals
Cochrane found only two small trials of probiotics ('good bacteria' supplements) for active Crohn's. The evidence is very uncertain, so we do not know whether probiotics help or are safe for this purpose.
Topics
Diet and nutrition
Medicines
Jargon explained
probiotic
very low certainty evidence
Cochrane
Systematic review
Sep 2019
Patients and professionals
Compares the medicines used to stop Crohn's returning after an operation. The evidence was not strong enough to say which works best. Cases of pancreatitis and low white blood cell counts were seen with azathioprine-type drugs.
Topics
Surgery
Medicines
Jargon explained
network meta-analysis
endoscopic relapse
postoperative recurrence
British Society of Gastroenterology (Gut)
Guideline
Jun 2025
For professionals
The UK specialists' full guideline for managing Crohn's and ulcerative colitis in adults, free to read. Beyond medicines and surgery, it covers special situations such as pregnancy and problems outside the gut. Written for clinicians, but useful background for patients who want the detail behind their care.
Topics
Medicines
Pregnancy and fertility
Beyond the gut
Jargon explained
guideline
network meta-analysis
extraintestinal manifestations
American College of Gastroenterology (Am J Gastroenterol)
Guideline
Jun 2025
For professionals
The American College of Gastroenterology's 2025 update on diagnosing and treating Crohn's in adults, replacing its 2018 guideline. It reflects how much treatment has changed in recent years. Like other US guidance, it is a useful comparison to UK practice rather than a guide to what the NHS offers.
Topics
Medicines
Diagnosis and tests
Research
Jargon explained
idiopathic
etiology
European Crohn's and Colitis Organisation (J Crohns Colitis)
Guideline
Oct 2024
For professionals
Europe's main expert guideline on which medicines to use for Crohn's disease, published as the first of a two-part set (the second covers surgery). It weighs up the trial evidence for steroids, immunosuppressants, biologics and newer tablets, including treatment of disease around the back passage. UK specialists use it alongside the BSG guideline.
Topics
Medicines
Biologics and newer medicines
Immunosuppressants
Around the bottom (perianal)
Jargon explained
biologic
immunomodulator
induction
maintenance
de-escalation
perianal fistula
GRADE
NICE
Guideline
Jun 2023
For professionals
NICE's appraisal recommending upadacitinib (Rinvoq), a tablet, for adults with moderate to severe Crohn's disease after a biologic has not worked, stopped working or was not tolerated, or when anti-TNF medicines are unsuitable.
Topics
Medicines
Biologics and newer medicines
Jargon explained
JAK inhibitor
small molecule
TNF-alpha inhibitor
American Gastroenterological Association (Gastroenterology)
Guideline
Jun 2021
For professionals
The American Gastroenterological Association's guideline on medicines for moderate to severe Crohn's, including fistulas around the anus. It rates the strength of evidence behind each drug option. It is American, so some drug choices and approvals differ from the NHS, but it is free to read in full and widely cited.
Topics
Medicines
Biologics and newer medicines
Around the bottom (perianal)
Jargon explained
luminal
perianal fistulizing
certainty of evidence
NICE
Guideline
Aug 2025
For professionals
NICE's appraisal allowing guselkumab (Tremfya) for adults with moderate to severe Crohn's disease when earlier treatment has not worked or cannot be tolerated and an anti-TNF medicine is not working or unsuitable. It asks clinicians to choose the least expensive of the suitable options, which include guselkumab, risankizumab and vedolizumab.
Topics
Biologics and newer medicines
Medicines
Jargon explained
IL-23 inhibitor
TNF-alpha inhibitor
conventional treatment
NICE
Guideline
Jul 2025
For professionals
NICE's appraisal allowing mirikizumab (Omvoh) to be used for adults with moderate to severe Crohn's disease after a previous biologic has not worked or was not tolerated, or when anti-TNF medicines are unsuitable.
Topics
Biologics and newer medicines
Medicines
Jargon explained
IL-23 inhibitor
TNF-alpha inhibitor
British Society of Gastroenterology (Gut)
Guideline
Jun 2025
For professionals
The 2025 update of the UK specialist guideline for adults with Crohn's or colitis, replacing the 2019 version. It is designed to sit alongside the IBD UK Standards and to encourage GPs to use the national referral pathway for bowel symptoms, so people get diagnosed sooner and more accurately. It was written without drug-company funding and is aimed mainly at the UK, though it can be used elsewhere.
Topics
Research
Medicines
Diagnosis and tests
Monitoring
Jargon explained
guideline
primary care
diagnostic pathway
NICE
Guideline
May 2023
For professionals
NICE's appraisal recommending risankizumab (Skyrizi) for people aged 16 and over with moderate to severe Crohn's disease after a previous biologic has failed or was not tolerated, or when anti-TNF medicines are unsuitable.
Topics
Biologics and newer medicines
Medicines
Jargon explained
IL-23 inhibitor
TNF-alpha inhibitor
biological treatment
ECCO and ESPGHAN (J Crohns Colitis)
Guideline
Feb 2021
For professionals
European children's gut specialists agreed how to treat Crohn's in children and teenagers. A key message is to spot early the children most likely to have a difficult course, such as those with disease around the bottom or narrowing or penetrating disease, so stronger treatment can start early and limit long-term bowel damage.
Topics
Children and young people
Medicines
Diet and nutrition
Biologics and newer medicines
Jargon explained
paediatric
penetrating disease
stricturing disease
exclusive enteral nutrition
anti-TNF
immunomodulator
therapeutic drug monitoring
NICE
Guideline
May 2019
For professionals
NICE's guideline for the NHS in England on managing Crohn's in children, young people and adults. It covers giving people information and support, treatment to bring Crohn's under control and keep it there, surgery, keeping remission after surgery, checking bone health, and pregnancy. It is about care after diagnosis rather than how Crohn's is diagnosed.
Topics
About Crohn's disease
Medicines
Surgery
Monitoring
Pregnancy and fertility
Children and young people
Steroids
Immunosuppressants
Jargon explained
remission
inducing remission
maintaining remission
osteopenia
NICE guideline
induce remission
maintain remission
glucocorticosteroid
thiopurine
TPMT
resection
stricture
NICE
Guideline
Jul 2017
For professionals
NICE's appraisal recommending ustekinumab (Stelara) for adults with moderate to severe Crohn's disease when standard treatment or an anti-TNF medicine has not worked, stopped working or cannot be used. It says the choice between biologics should be made with the patient, using the cheapest suitable option.
Topics
Biologics and newer medicines
Medicines
Jargon explained
interleukin inhibitor
TNF-alpha inhibitor
biological therapy
NICE
Guideline
Aug 2015
For professionals
NICE's appraisal recommending vedolizumab (Entyvio) for adults with moderate to severe Crohn's disease when an anti-TNF medicine has failed, stopped working or is unsuitable. It is given as a planned course and reassessed at 12 months.
Topics
Biologics and newer medicines
Medicines
Jargon explained
anti-TNF
TNF-alpha inhibitor
patient access scheme
moderately to severely active
NICE
Guideline
May 2010
For professionals
NICE's appraisal approving infliximab and adalimumab on the NHS for adults with severe active Crohn's disease when standard treatments such as steroids or immunosuppressants have not worked or cannot be used. It applies to biosimilar versions too, and says treatment should be reviewed at least every 12 months to decide whether to continue.
Topics
Biologics and newer medicines
Medicines
Jargon explained
anti-TNF
biosimilar
conventional therapy
severe active Crohn's disease
British Society of Gastroenterology
Guideline
Jun 2025
For professionals
The current UK specialist guideline for managing IBD in adults, replacing the 2019 version. It is designed to sit alongside the IBD Standards and encourage use of the national primary care pathway for lower gut symptoms so diagnosis is quicker and more accurate. Among its general principles, it recommends classifying Crohn's using the Montreal system.
Topics
About Crohn's disease
Diagnosis and tests
Medicines
Monitoring
Complications
Surgery
Jargon explained
Montreal classification
remission
endoscopic remission
inflammatory bowel disease
advanced therapy
GRADE
induction
maintenance
Gastroenterology
Guideline
Apr 2021
For professionals
An international expert agreement on what 'treat to target' should aim for in IBD. Short-term goals are feeling better and getting blood and poo inflammation tests back to normal. Long-term goals include a healed bowel lining seen at endoscopy, no disability, a normal quality of life, and normal growth in children. Healing through the full bowel wall in Crohn's is not yet a formal target but is a sign of deeper remission.
Topics
Monitoring
Research
Medicines
Jargon explained
treat to target
endoscopic healing
transmural healing
biomarker
calprotectin
CRP
clinical remission
NICE
Guideline
May 2019
For professionals
The full list of NICE recommendations. It says a standard steroid is usually the first option for a first flare, budesonide or a 5-ASA may be considered for some people who cannot take standard steroids, and liquid feeds may be considered for children worried about growth. It asks for a TPMT check before azathioprine or mercaptopurine, suggests azathioprine with a short course of metronidazole after a complete ileocolonic resection, and says surgery can be considered early when the disease is limited to the end of the small bowel.
Topics
Steroids
Immunosuppressants
Surgery
Medicines
Jargon explained
TPMT
budesonide
aminosalicylate
enteral nutrition
ileocolonic resection
metronidazole
balloon dilation
distal ileum
Gut (BMJ) via PubMed Central
Guideline
Sep 2019
For professionals
The free full text of the 2019 BSG guideline, written with surgeons, specialist nurses, dietitians, radiologists, GPs and Crohn's & Colitis UK. It reviewed a very large body of research to make recommendations for adults with IBD. It has been replaced by the 2025 guideline but is a freely readable reference on diagnosis and assessment.
Topics
About Crohn's disease
Diagnosis and tests
Monitoring
Research
Medicines
Surgery
Jargon explained
inflammatory bowel disease
consensus guideline
IBD